---
title: "Mochida Pharmaceutical Acquires Stake in And Pharma to Boost Core Business"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/258308503.md"
description: "Mochida Pharmaceutical Co., Ltd. has acquired a 20% stake in And Pharma Co., Ltd., making it an equity-method affiliate. This strategic move aims to enhance Mochida's core pharmaceutical business by leveraging its biosimilar development expertise alongside And Pharma's manufacturing capabilities. The collaboration with Itochu Corporation is expected to strengthen And Pharma's subsidiaries and contribute to Japan's medical economy by providing high-quality generics and biosimilars. The current analyst rating for Mochida's stock is a Hold with a price target of Yen3460.00."
datetime: "2025-09-22T08:52:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/258308503.md)
  - [en](https://longbridge.com/en/news/258308503.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/258308503.md)
---

# Mochida Pharmaceutical Acquires Stake in And Pharma to Boost Core Business

The latest update is out from Mochida Pharmaceutical Co., Ltd. ( (JP:4534) ).

Mochida Pharmaceutical Co., Ltd. has announced its decision to acquire 20% of And Pharma Co., Ltd., making it an equity-method affiliate, as part of its strategy to enhance its core pharmaceutical business. This acquisition aims to create synergies by combining Mochida’s expertise in biosimilar development with And Pharma’s manufacturing capabilities, while also collaborating with Itochu Corporation to strengthen the business foundation of And Pharma’s subsidiaries. The move is expected to contribute to a stable supply of pharmaceuticals and support Japan’s medical economy by providing high-quality generics and biosimilars.

The most recent analyst rating on (JP:4534) stock is a Hold with a Yen3460.00 price target. To see the full list of analyst forecasts on Mochida Pharmaceutical Co., Ltd. stock, see the JP:4534 Stock Forecast page.

**More about Mochida Pharmaceutical Co., Ltd.**

Mochida Pharmaceutical Co., Ltd. operates in the pharmaceutical industry with a focus on developing new drugs, generic drugs, including authorized generics and biosimilars, and has a strategic emphasis on global expansion. The company is structured around three business pillars: pharmaceutical, biomaterials, and healthcare, aiming to offer distinctive products that meet market needs.

**YTD Price Performance:** -6.43%

**Average Trading Volume:** 24,050

**Technical Sentiment Signal:** Strong Buy

**Current Market Cap:** Yen110.8B

Learn more about 4534 stock on TipRanks’ Stock Analysis page.

## Related News & Research

- [Qualcomm Stock's Momentum Score Surges Amid AI Optimism And Data Center Growth Plans](https://longbridge.com/en/news/285357301.md)
- [The latest sign of Sandisk's ascent: It's now bigger than Western Digital, which spun it off](https://longbridge.com/en/news/285267162.md)
- [Nvidia Just Made A 175-Year-Old Glass Stock Look Like An AI Rocket](https://longbridge.com/en/news/285395436.md)
- [ANALYSIS-Bets surge against Nike, heaping pressure on CEO Hill](https://longbridge.com/en/news/285248222.md)
- [SanDisk Surges 10% Past Record Highs After Locking In $42 Billion In AI Deals](https://longbridge.com/en/news/285240959.md)